Literature DB >> 20357284

Clinical practice. Prolactinomas.

Anne Klibanski1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20357284     DOI: 10.1056/NEJMcp0912025

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  47 in total

Review 1.  Diagnosis and Management of pituitary disease with focus on the role of Magnetic Resonance Imaging.

Authors:  Amit Mahajan; Richard A Bronen; Ali Y Mian; Sacit Bulent Omay; Dennis D Spencer; Silvio E Inzucchi
Journal:  Endocrine       Date:  2020-03-11       Impact factor: 3.633

Review 2.  Is there a role for early chemotherapy in the management of pituitary adenomas?

Authors:  Andrew L Lin; Melissa W Sum; Lisa M DeAngelis
Journal:  Neuro Oncol       Date:  2016-04-21       Impact factor: 12.300

Review 3.  Radiotherapy for prolactin-secreting pituitary tumors.

Authors:  Lawrence J Sheplan Olsen; Lizbeth Robles Irizarry; Samuel T Chao; Robert J Weil; Amir H Hamrahian; Betul Hatipoglu; John H Suh
Journal:  Pituitary       Date:  2012-06       Impact factor: 4.107

4.  The anterior skull base nasal inventory (ASK nasal inventory): a clinical tool for evaluating rhinological outcomes after endonasal surgery for pituitary and cranial base lesions.

Authors:  Andrew S Little; Heidi Jahnke; Peter Nakaji; John Milligan; Kristina Chapple; William L White
Journal:  Pituitary       Date:  2012-12       Impact factor: 4.107

5.  Risk of cardiac valve regurgitation with dopamine agonist use in Parkinson's disease and hyperprolactinaemia: a multi-country, nested case-control study.

Authors:  Gianluca Trifirò; M Mostafa Mokhles; Jeanne P Dieleman; Eva M van Soest; Katia Verhamme; Giampiero Mazzaglia; Ron Herings; Cynthia de Luise; Douglas Ross; Guy Brusselle; Annamaria Colao; Wilhelm Haverkamp; Rene Schade; Guy van Camp; Renzo Zanettini; Miriam C Sturkenboom
Journal:  Drug Saf       Date:  2012-02-01       Impact factor: 5.606

Review 6.  Hyperprolactinaemia.

Authors:  Angela X Chen; Morton G Burt
Journal:  Aust Prescr       Date:  2017-12-04

7.  Significance of surgical management for cystic prolactinoma.

Authors:  Toshihiro Ogiwara; Tetsuyoshi Horiuchi; Alhusain Nagm; Tetsuya Goto; Kazuhiro Hongo
Journal:  Pituitary       Date:  2017-04       Impact factor: 4.107

8.  Dopamine agonist therapy induces significant recovery of HPA axis function in prolactinomas independent of tumor size: a large single center experience.

Authors:  Christine G Yedinak; Isabelle Cetas; Alp Ozpinar; Shirley McCartney; Aclan Dogan; Maria Fleseriu
Journal:  Endocrine       Date:  2016-07-26       Impact factor: 3.633

9.  BMI, apolipoprotein B/apolipoprotein A-I ratio, and insulin resistance in patients with prolactinomas: a pilot study in a Chinese cohort.

Authors:  Xiao-Bing Jiang; Dong-Sheng He; Zhi-Gang Mao; Xiang Fan; Ni Lei; Bin Hu; Bing-Bing Song; Yong-Hong Zhu; Hai-Jun Wang
Journal:  Tumour Biol       Date:  2013-01-24

10.  Investigation of impulsivity in patients on dopamine agonist therapy for hyperprolactinemia: a pilot study.

Authors:  Maya Barake; A Eden Evins; Luke Stoeckel; Gladys N Pachas; Lisa B Nachtigall; Karen K Miller; Beverly M K Biller; Nicholas A Tritos; Anne Klibanski
Journal:  Pituitary       Date:  2014-04       Impact factor: 4.107

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.